 |
|
Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
Oh Young Bang, Keun-Sik Hong, Ji Hoe Heo
J Stroke. 2016;18(2):169-178. Published online 2016 May 10 DOI: https://doi.org/10.5853/jos.2016.00052
|
|
Citations to this article as recorded by
 Ischaemic stroke in a patient with non-valvular atrial fibrillation (NVAF) despite non-vitamin K oral anticoagulant (NOAC) therapy
Simon Zhen, Fion Chu, Afek Kodesh, Jisoon Kim
BMJ Case Reports.2024; 17(1): e258761. CrossRef “East Asian Paradox” Revisited: Precision Medicine for Antithrombotic Strategies Tailored to Atherothrombotic Cardiovascular Risks
Young-Hoon Jeong, Udaya S. Tantry, Mohamed Omar, Eliano Navarese, Diana A. Gorog, Paul A. Gurbel
Journal of Cardiovascular Intervention.2024;[Epub] CrossRef Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
Oh Young Bang, Kyoung-Min Park, Dong Seop Jeong
Journal of Stroke.2023; 25(2): 199. CrossRef Effects of Direct Oral Anticoagulants’ Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis
Maria Giulia Mosconi, Giorgio Maraziti, Maurizio Paciaroni, Michela Giustozzi, Maria Cristina Vedovati, Giulio Bogliari, Chiara Urbini, Laura Traballi, Valeria Caso
European Neurology.2023; 86(1): 13. CrossRef Pragmatic Clinical Studies: An Emerging Clinical Research Discipline for Improving Evidence-Based Practice of Cardiovascular Diseases in Asia
Dong Zhao, Chen Yao
Korean Circulation Journal.2022; 52(6): 401. CrossRef Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
Juan Tamargo, Juan Carlos Kaski, Takeshi Kimura, Jack Charles Barton, Ko Yamamoto, Maki Komiyama, Heinz Drexel, Basil S Lewis, Stefan Agewall, Koji Hasegawa
European Heart Journal - Cardiovascular Pharmacotherapy.2022; 8(7): 738. CrossRef Do Apixaban Plasma Levels Relate to Bleeding? The Clinical Outcomes and Predictive Factors for Bleeding in Patients with Non-Valvular Atrial Fibrillation
Sutee Limcharoen, Manat Pongchaidecha, Piyarat Pimsi, Sarawuth Limprasert, Juthathip Suphanklang, Weerayuth Saelim, Wichai Santimaleeworagun, Pornwalai Boonmuang
Biomedicines.2022; 10(8): 2001. CrossRef Left atrial appendage occlusion for ischemic stroke prevention in patients with non-valvular atrial fibrillation: clinical expert opinion and consensus statement for the Asian-Pacific region
Edgar Tay, Biswajit Paul, Jason Sharp, Dennis Wang, Angus Shing Fung Chui, Prakash Kumar Hazra, Teguh Santoso, Bert Albers, Hans-Christoph Diener, Thorsten Lewalter, Andrew Wong
Journal of Interventional Cardiac Electrophysiology.2021; 61(2): 269. CrossRef Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences
Hyun Kuk Kim, Udaya S. Tantry, Hyun-Woong Park, Eun-Seok Shin, Tobias Geisler, Diana A. Gorog, Paul A Gurbel, Young-Hoon Jeong
Korean Circulation Journal.2021; 51(3): 202. CrossRef The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Hyun Kuk Kim, Udaya S. Tantry, Sidney C. Smith, Myung Ho Jeong, Seung-Jung Park, Moo Hyun Kim, Do-Sun Lim, Eun-Seok Shin, Duk-Woo Park, Yong Huo, Shao-Liang Chen, Zheng Bo, Shinya Goto, Takeshi Kimura, Satoshi Yasuda, Wen-Jone Chen, Mark Chan, Daniel Arad
Thrombosis and Haemostasis.2021; 121(04): 422. CrossRef Real-world oral anticoagulants for Asian patients with non-valvular atrial fibrillation
Seung Min Kim, Eun-Tae Jeon, Jin-Man Jung, Ji-Sung Lee
Medicine.2021; 100(32): e26883. CrossRef Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study
Stefan H. Hohnloser, Hugh Calkins, Stephan Willems, Atul Verma, Richard Schilling, Ken Okumura, Matias Nordaby, Eva Kleine, Branislav Biss, Edward P. Gerstenfeld
Journal of Interventional Cardiac Electrophysiology.2019; 55(2): 145. CrossRef Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry
Karen P. Phillips, Teguh Santoso, Prashanthan Sanders, Jeffrey Alison, Jason Leung Kwai Chan, Hui-Nam Pak, Mann Chandavimol, Kenneth M. Stein, Nicole Gordon, Omar Bin Razali
IJC Heart & Vasculature.2019; 23: 100358. CrossRef Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
Yi‐Hsin Chan, Lai‐Chu See, Hui‐Tzu Tu, Yung‐Hsin Yeh, Shang‐Hung Chang, Lung‐Sheng Wu, Hsin‐Fu Lee, Chun‐Li Wang, Chang‐Fu Kuo, Chi‐Tai Kuo
Journal of the American Heart Association.2018;[Epub] CrossRef Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation
Yun Kyung Park, Mi Ji Lee, Jae Ha Kim, Jin Soo Lee, Rae Woong Park, Gyeong-Moon Kim, Chin-Sang Chung, Kwang Ho Lee, June Soo Kim, Soo-Youn Lee, Oh Young Bang
Journal of Stroke and Cerebrovascular Diseases.2017; 26(6): 1383. CrossRef Implications of CHA2DS2-VASc Score in Stroke Patients with Atrial Fibrillation: An Analysis of 938 Korean Patients
Jaechun Hwang, Jong-Won Chung, Mi Ji Lee, Gyeong-Moon Kim, Chin-Sang Chung, Kwang Ho Lee, Oh Young Bang
European Neurology.2017; 77(5-6): 307. CrossRef
|